Modulation of Epidermal Growth Factor Release by Biopolymer-Coated Liposomes.

This work describes the development of polysaccharide-coated liposomes to modulate the delivery of epidermal growth factor (EGF), with the aim to produce different EGF release profiles depending on the milieu of infected wounds. For this purpose, cationic liposomes were coated with one layer of sodium alginate (ALG) followed by one layer of chitosan (CHI) using the layer-by-layer (LbL) technique. The coated liposomes exhibited apparent hydrodynamic diameters of 278 ± 36 and 216 ± 96 nm for Lip-ALG and Lip-ALG-CHI, respectively. Thus, it appears that adding the CHI layer compacted the Lip-ALG one. The incorporation efficiency of EGF was a maximum of 55% for liposomes with a polymeric coating. In vitro release experiments showed that Lip-ALG-CHI exhibits a higher release rate constant under acidic pH conditions, resembling those of infected tissue. Using an ex vivo model of EGF release in porcine ear skin, these liposomes were found to accumulate in the epidermis. Thus, coated liposomes could represent a local EGF delivery mechanism to promote healing.

Development, characterization and antimicrobial activity of sodium dodecyl sulfate-polysaccharides capsules containing eugenol.

This work describes the production of polysaccharide multilayer capsules to control the release of Eugenol (Eug) and enabling its use as an antimicrobial agent. For this propose, oil-in-water nanoemulsions of sodium dodecyl sulfate were coated with alternating depositions of chitosan and carboxymethylcellulose using the Layer-by-Layer (LbL) technique, resulting in capsules containing 1-5 layers. The average size ranged from 188 ±â€¯30 (LbL1) to 1415 ±â€¯517 nm (LbL5). The maximum incorporation efficiency was 70.8 ±â€¯2.7 % for Eug-SDS-LbL1. The initial burst releases decreased in proportion to the increase in the number of polysaccharide layers (22.3 ±â€¯3.1 %-12.8 ±â€¯1.6 %), and are influenced by the pH. These systems exhibited antifungal activity against Aspergillus niger, Trichoderma sp, Gliocladium sp, and Candida albicans, and Eug minimum inhibitory concentrations were lower as compared to those of the free agent. Therefore, these capsules represent promising antifungal materials for application in various fields.